I believe the Prescription Drug User Fee Act reauthorization gives an opportunity to review the ways in which we can help improve the FDA approval process.
Editor's note · Context
Gingrey discusses the potential benefits of reauthorizing the Prescription Drug User Fee Act.
Share & report
More from Phil Gingrey
I don't think that anyone here would disagree that the Medicare program of today is in trouble.
I am in opposition to the amendment. To a large extent, we are here to represent the voices of our constituents, each of us, approximately 700,000, and the voices of our State, our State government, being firm believers in the 10th…
I still believe in the amazing potential that health information technologies will have on the practice of medicine.
I want to ask you to commit to me today to work with my office to fix the breakpoint issue, as well as look toward other ideas to address the epidemic of antibiotic resistance, one of the chief threats to public health today.





